The prostate is a small gland located in the male reproductive system that's essential for producing seminal fluid. When it's ...
SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adjuvant radiotherapy (RT) after radical prostatectomy did not improve outcomes in prostate cancer as compared with ...
Of the 20,000 men diagnosed with prostate cancer in the UK each year, nearly one in ten will undergo radical prostatectomy to surgically remove the affected gland. Martin Woods, 45, an executive ...
Active surveillance clearly avoids overtreatment during the first 5 years after radical prostatectomy, but SRT doses are usually higher than ART doses. For some patients, important quality-of-life ...
The etiology and pathophysiology of post-prostatectomy erectile dysfunction is not yet fully understood. However, it appears that injury to the neurovascular bundles (NVBs) occurs secondary to one ...
New therapies being developed are moving into earlier lines of therapy, with the idea that most patients with early-stage ...
Results from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiotherapy ...
ArteraAI, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the validation of its first multimodal artificial intelligence (MMAI) digital ...
Total operating expenses, which consist of research and development (“R&D”), general and administrative (“G&A”), and selling and distribution (“S&D”) expenses, were approximately $8.8 million in the ...
"Again, no patient had a confirmed BCR 2 years after radical prostatectomy, defined as two consecutive PSA [prostate specific antigen] values greater than 0.2 nanograms per milliliter." ...